ATLANTA — One in three teenage girls have rolled up their sleeves for a
vaccine against cervical cancer, but vaccination rates vary dramatically between
states, according to a federal report released Thursday.
The highest rates were in Rhode Island, New Hampshire and Massachusetts, where
more than half of girls ages 13 through 17 got at least one dose of the
three-shot vaccination. The lowest rates were in Mississippi, Georgia and South
Carolina, where fewer than 20 percent got at least one shot.
The report is the first to give state-by-state rates for Merck's Gardasil
vaccine. It targets strains of the sexually transmitted human papillomavirus
that cause about 70 percent of cervical cancers. It came on the market in 2006.
Health officials recommend that girls get the shots when they are 11 or 12, if
possible, before they become sexually active so they have immunity before they
are first infected. The shots are approved for females 9 through 26.
The Centers for Disease Control and Prevention study involved a 2008 telephone
survey of the parents of nearly 18,000 adolescents, who allowed researchers to
check their kids' vaccination records.
Nationally, there was an increase in the percentage of teens ages 13 to 17
vaccinated against meningitis, tetanus, diphtheria and other illnesses. The
agency also noted a rise since 2007 in the percentage of teenage girls who had
gotten at least the first dose in the three-shot vaccination series against
cervical cancer.
In 2007, about 25 percent had gotten a first dose of the vaccine. Last year, it
rose to about 37 percent.
CDC study also found that the number of girls who got the whole three-dose
series was only 18 percent and the rate was higher for white girls than for
blacks or Hispanics.
Vaccine proponents had been hoping for higher vaccination rates, saying the
shots could dramatically reduce the nearly 4,000 cervical cancer deaths that
occur each year in the United States.
It's not clear why state vaccination rates vary so much, but several factors
could be involved, said Dr. Melinda Wharton, an administrator of the CDC center
that did the research.
Money is an issue. Retailing at $390 for the three-dose series, Gardasil is the
most expensive childhood vaccine.
Many health insurers pay for the shots, but health officials noted variations in
public insurance coverage. A federal program pays for certain children,
including those who are uninsured or are in state Medicaid programs, but some
states were slower to take advantage of it than others.
Also, it takes three trips to the doctor over six months to get all the shots,
and some parents are unable or unwilling to take their kids to the doctor that
often.
In South Carolina, many parents have said they are concerned about the safety of
the vaccine or that they don't understand why a girl should get vaccinated
before she's sexually active, said Heather Brandt, a University of South
Carolina public health researcher.
"It's disturbing to see those states at the lower end of participation," she
added. "Because those are states with some of the highest rates of cervical
cancer."
On the Net:
Source : The Associated Press
